FDA Approved a $300,000-a-Year Drug Its Own Experts Didn't Believe Worked | CancerBuster
Most of the time, the pharmaceutical conscripts within the FDA will give the ceremonial nod first before a drug is allowed to flood the market. But a recent Wall Street Journal In-depth Report is now saying that sometimes an aggressive lobbying from the drug manufacturers, which have gained support from the patient’s loved ones, canRead More